TG Therapeutics
TGTX
TGTX
67 hedge funds and large institutions have $122M invested in TG Therapeutics in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 2 closing their positions.
Holders
67
Holders Change
+16
Holders Change %
+31.37%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
19
Closed
2
Calls
$7.49M
Puts
$960K
Net Calls
+$6.53M
Net Calls Change
+$5.01M
Top Buyers
| 1 |
VAM
1
Visium Asset Management
New York
|
$5.92M |
| 2 |
2
Millennium Management
New York
|
$2.54M |
| 3 |
TC
3
TFS Capital
West Chester,
Pennsylvania
|
$3.26M |
| 4 |
CCI
4
Columbus Circle Investors
|
$3.84M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$1.71M |
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$21.4M |
| 2 |
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
|
$563K |
| 3 |
SGAM
3
Smith Group Asset Management
Dallas,
Texas
|
$770K |
| 4 |
4
Morgan Stanley
New York
|
$177K |
| 5 |
5
Jennison Associates
New York
|
$3.84M |
